Portal de Periódicos da CAPES

MRSA dynamic circulation between the community and the hospital setting: New insights from a cohort study

2019; Elsevier BV; Volume: 80; Issue: 1 Linguagem: Inglês

10.1016/j.jinf.2019.10.001

1532-2742

Danilo Barcudi, Ezequiel Sosa, Ricardo Lamberghini, Analía Garnero, Dario Tosoroni, L Decca, Liliana González, María A. Kuyuk, Teresa Margarita Torres López, I. Herrero, Paulo R. Cortes, M Figueroa, Ana L. Egea, Paula Gagetti, Darío Fernández Do Porto, Alejandra Corso, Adrián G. Turjanski, José Luís Bocco, Claudia Sola,

Infective Endocarditis Diagnosis and Management

Dissemination of methicillin-resistant-Staphylococcus aureus/(MRSA) is a worldwide concern both in hospitals [healthcare-associated-(HA)-MRSA] and communities [community-associated-(CA)-MRSA]. Knowledge on when and where MRSA colonization is acquired and what clones are involved is necessary, to focus efforts for prevention of hospital-acquired MRSA-infections. Methods A prospective/longitudinal cohort study was performed in eight Argentina hospitals (Cordoba/ October-December/2014). Surveillance cultures for MRSA (nose-throat-inguinal) were obtained on admission and at discharge. MRSA strains were genetically typed as CA-MRSAG and HA-MRSAG genotypes. Results Overall, 1419 patients were screened and 534 stayed at hospital for ≥3 days. S. aureus admission prevalence was 30.9% and 4.2% for MRSA. Overall MRSA acquisition rate was 2.3/1000 patient-days-at-risk with a MRSA acquisition prevalence of 1.96% (95%CI: 1.0%-3.4%); 3.2% of patients were discharged back to community with MRSA. CA-MRSAG accounted for 84.6% of imported, 100.0% of hospital-acquired and 94% of discharged MRSA strains. Most imported and acquired MRSA strains belonged to two major epidemic CA-MRSA clones spread in Argentina: PFGEtypeI-ST5-IVa-t311-PVL+ and PFGEtypeN/ST30-IVc-t019-PVL+. Conclusions CA-MRSA clones, particularly ST5-IV-PVL+ and ST30-IV-PVL+, with main reservoir in the community, not only enter but also are truly acquired within hospital, causing healthcare-associated-hospital-onset infections, having a transmission capacity greater or similar than HA-MRSAG. This information is essential to develop appropriate MRSA infection prevention-control programs, considering hospital and community.